In addition, this patient who experienced a 20% tumor reduction and PFS more than 1 year had an approximately 40% increase in CD3+ T-cells and a marked decrease in cancer-cell Ki-67, indicating a reduction in tumor proliferation. This evidence concerns the gene MKI67 and cancer.